DE1462090U - - Google Patents

Info

Publication number
DE1462090U
DE1462090U DENDAT1462090D DE1462090DU DE1462090U DE 1462090 U DE1462090 U DE 1462090U DE NDAT1462090 D DENDAT1462090 D DE NDAT1462090D DE 1462090D U DE1462090D U DE 1462090DU DE 1462090 U DE1462090 U DE 1462090U
Authority
DE
Germany
Prior art keywords
wnd
hmm
tmt
tmn
wprwth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1462090D
Other languages
German (de)
English (en)
Publication of DE1462090U publication Critical patent/DE1462090U/de
Active legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1462090D Active DE1462090U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1462090U true DE1462090U (cg-RX-API-DMAC7.html)

Family

ID=768940

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1462090D Active DE1462090U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1462090U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
Cicero et al. Disputationes Tusculanae
WO2021110063A8 (en) New conjugates of peptides and polysaccharide
Henry et al. Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature
Hamood et al. Effects of recombinant human granulocyte‐colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti‐C. albicans resistance: Die Wirkung von menschlichem Granulozytenkolonien stimulierendem Faktor auf neutropenische, C. albicans‐infizierte Mäuse: Beschleunigte Normalisierung der Granulozytenzahl und Verstärkung der Resistenz gegenüber C. albicans
Sharma et al. Telmisartan in patients with mild/moderate hypertension and chronic kidney disease
Lee et al. An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B
DE1516942U (cg-RX-API-DMAC7.html)
DE1426937U (cg-RX-API-DMAC7.html)
DE1519488U (cg-RX-API-DMAC7.html)
DE1773060U (de) Kabellegegeraet fuer einachsschlepper.
UEHARA et al. A case of bacterial aneurysm of the common carotid artery caused by neck lymphadenitis
Giry et al. Efficacy of different Piperacillin-Tazobactam-Amikacin regimens against ESBL Escherichia coli in a Hollow Fiber Infection Model simulating sepsis augmented renal clearance
DE1439631U (cg-RX-API-DMAC7.html)
Milanović Litre et al. QRS morphologies associated with left bundle branch area pacing
DE1416205U (cg-RX-API-DMAC7.html)
DE1485243U (cg-RX-API-DMAC7.html)
Siklosi Some Reflections on the Interpretation of Theou Bia
DE1504750U (cg-RX-API-DMAC7.html)
DE1464912U (cg-RX-API-DMAC7.html)
MX2022007813A (es) Formulacion a base de extracto etanolico de calices de hibiscus sabdariffa para su uso como enjuague bucal.
DE1419342U (cg-RX-API-DMAC7.html)
Antoniucci et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction
DE1396902U (cg-RX-API-DMAC7.html)
DE1434630U (cg-RX-API-DMAC7.html)
DE1439478U (cg-RX-API-DMAC7.html)